Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Stay ahead in the global glaucoma surgery devices market with an interactive, Excel-based market model report from GlobalData. It helps you explore market size trends, intervention volumes, pricing and competitive positioning across major countries and segments through 2036.

Built for strategy teams, investors, and commercial leaders, this model combines epidemiology-driven demand insights with practical market-access intelligence. As a result, you can assess where growth may accelerate and where barriers may emerge.

Glaucoma Surgery Devices are used to augment normal physiologic aqueous outflow pathways to provide effective intraocular pressure control. This category includes glaucoma drainage devices and Minimally Invasive Glaucoma Surgery (MIGS).

Glaucoma is an ocular disease which affects the optic nerve of the iris due to the fluid buildup in front of the eyes. It is one of the leading causes of vision loss and blindness globally. The risk for developing glaucoma increases with age, and as the global population is aging the prevalence of glaucoma is also increasing globally.

Each of the covered 39 countries’ colour-coded and fully-sourced market models is equipped with epidemiology-based indications with intervention volumes.

The interactive Excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Glaucoma Surgery Devices and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Glaucoma Surgery Devices market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country-level market-specific insights:

• Qualitative market-specific information is available, with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Glaucoma Surgery Devices market.
• Competitive dynamics insights and trends provided for Venous Stents market.

Drive the understanding of the market by getting the veritable big picture, including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies referenced: Glaukos Corp, Allergan Aesthetics, Alcon Inc, Johnson & Johnson Vision Care Inc, New World Medical, Aurolab, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd and others.

Countries covered (39): United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Each country model is colour-coded, fully sourced and built for easy navigation. It covers:

• Market value and volume trends

• Product usage and average selling prices

• Intervention volumes linked to epidemiology

• Company share and ranking insights (where available)

• Analyst commentary for qualitative context

Scope

This Excel deliverable gives important, expert insight you won’t find in any other source. The interactive model illustrates qualitative and quantitative trends within the specified market. Glaucoma remains a major cause of vision loss globally. Moreover, ageing populations are increasing the long-term patient pool. Therefore, understanding procedure growth, pricing pressure and reimbursement dynamics can be critical for market planning.

This model helps you:

• Track how intervention volumes may evolve by country and segment

• Identify where pricing and adoption dynamics are changing

• Evaluate market access barriers before committing resources

• Compare opportunities across mature and emerging markets

Who should read this Glaucoma Surgery Devices Market Model?

This Excel model is especially relevant if you need to size opportunities, assess competitors or plan market entry.

It is ideal for:

• CMO and Strategy Leaders shaping long-term portfolio and investment priorities

• Business Development and Licensing Teams evaluating in-licensing and out-licensing options

• Sales and Marketing Leaders refining segmentation, targeting and competitive messaging

• Sourcing and Procurement Executives assessing supply base structure and vendor exposure

• Private Equity and Healthcare Investors screening targets and validating growth assumptions

• Market Access and HEOR Teams reviewing reimbursement and regulatory constraints

Reasons to Buy

The model will enable you to –

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.

– Develop business strategies by understanding the trends shaping and driving Glaucoma Surgery Devices.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Glaucoma Surgery Devices market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

– Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

– Track device sales in the global and country-specific Glaucoma Surgery Devices market from 2015-2036.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.